IO Essentials: Patient Education Role Playing

In these videos, the IO Essentials faculty members illustrate how they talk with patients about immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI) therapies. From these experts, you may garner communication pearls that are helpful as you develop or refine your educational strategy related to irAE management.

These videos are for your educational purposes only at this point (ie, please do not share the link to these video with patients). Soon, we will make these videos available for patients to access directly through a designated portal/video-sharing service. In addition, we anticipate further distribution with the tumor-specific advocacy organizations we have partnered with for distribution of patient-related materials. Stay tuned—we will make you aware when those direct-patient access resources are available!

Patient Videos

In this video, Eric Whitman, MD, FACS, of the Atlantic Health System, provides tips for patients about the proper use of corticosteroids for immune-related adverse events.

In this video, Eric D. Whitman, MD, FACS, comments on the common symptom of fatigue and how that will be worked up in the patient receiving immune checkpoint inhibitors.

In this video, Laura J. Zitella, MS, RN, ACNP-BC, AOCN^®, of the University of California San Francisco, discusses hypothyroidism and what patients receiving immune checkpoint inhibitors should be on the lookout for.

In this video, Laura J. Zitella, MS, RN, ACNP-BC, AOCN^®, of the University of California San Francisco, discusses liver problems (hepatitis) in patients receiving immune checkpoint inhibitor therapy.

In this video, Laura J. Zitella, MS, RN, ACNP-BC, AOCN^®^,of the University of California San Francisco, discusses graft-vs-host disease and what patients receiving immune checkpoint inhibitors should be on the lookout for.

In this video, Jessica Mitchell, APRN, CNP, MPH, of the Mayo Clinic, discusses the side effects that can happen with immune checkpoint inhibitor therapy and what patients should be on the lookout for.

In this video, Jessica Mitchell, APRN, CNP, MPH, of the Mayo Clinic, discusses the symptom of shortness of breath and how it is evaluated in patients undergoing immunotherapy.

In this video, Jessica Mitchell, APRN, CNP, MPH, of the Mayo Clinic, discusses the muscle problems that can happen with immune checkpoint inhibitor therapy and what patients should be on the lookout for.

In this video, Jessica Mitchell, APRN, CNP, MPH, of the Mayo Clinic, discusses the nerve problems that can occur with immune checkpoint inhibitors and what patients should be on the lookout for.

In this video, Jessica Mitchell, APRN, CNP, MPH, of the Mayo Clinic, discusses the diarrhea and colitis (inflammation of the colon) that can occur with immune checkpoint inhibitors.

In this video, Mollie Lehner Reed, MSN, RN, ACPP-BC, of Tennessee Oncology, discusses MSI-H and dMMR, explaining why these markers are relevant to the use of immune checkpoint inhibitors.

In this video, Mollie Lehner Reed, MSN, RN, ACPP-BC, of Tennessee Oncology, discusses rash occurring in patients receiving immune checkpoint inhibitors.

In this video, Laura Wood, RN, MSN, OCN, of the Cleveland Clinic, explains how the team will evaluate fatigue in a patient undergoing immune checkpoint inhibitor therapy.

In this video, Laura Wood, RN, MSN, OCN, of the Cleveland Clinic, discusses diarrhea in patients undergoing immune checkpoint inhibitor therapy.

In this video, Casey Fazer, PA-C, of the Mayo Clinic, discusses mucositis (mouth sores/inflammation) in patients with head-and-neck cancer receiving immune checkpoint inhibitors.

In this video, Casey Fazer, PA-C, of the Mayo Clinic, discusses counseling to ensure adequate nutrition for patients with HNSCC experiencing mouth/oral problems from immune checkpoint inhibitors.

In this video, Casey Fazer, PA-C, of the Mayo Clinic, discusses the management of swelling (edema) in patients receiving immune checkpoint inhibitors.

In this video, Christine Kim, NP, of the University of California, San Francisco, discusses the symptoms and management of thyroiditis (inflammation of the thyroid gland) in patients receiving immune checkpoint inhibitors.

In this video, Christine Kim, NP, discusses diabetes (high glucose/sugar) in patients receiving immune checkpoint inhibitors, with a focus on what patients should look out for and what they can expect if they develop this side effect.

In this video, Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP, of Yale University, discusses the symptom of shortness of breath in patients with lung cancer receiving immune checkpoint inhibitors, with a focus on what patients should be on the lookout for.

In this video, Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP, of Yale University, discusses adrenal insufficiency in patients receiving immune checkpoint inhibitor and what patients should be on the lookout for.

In this video, Brianna Hoffner, MSN, AOCNP, RN, of the University of Colorado, discusses key immune-related adverse events (irAEs) associated with immune checkpoint inhibitors.

In this video, Brianna Hoffner, MSN, AOCNP, RN, of the University of Colorado, discusses steps patients can take to deal with the skin toxicities associated with use of immune checkpoint inhibitors.

In this video, Brianna Hoffner, MSN, AOCNP, RN, of the University of Colorado, talks about the workup of confusion in patients receiving immune checkpoint inhibitors.

In this video, Eric D. Whitman, MD, FACS, of the Atlantic Health System, discusses immune-related adverse events associated with immune checkpoint inhibitors.

In this video, Paula Anastasia, RN, MN, AOCN^®, of Cedars-Sinai Medical Center, Los Angeles, describes the nerve problems patients can experience with immune checkpoint inhibitor therapy. She discusses what patients should be on the lookout for.

In this video, Paula Anastasia, RN, MN, AOCN^®, of Cedars-Sinai Medical Center, Los Angeles, describes the problem of diabetes (high blood sugar) that patients can experience with immune checkpoint inhibitor therapy. She discusses what patients should be on the lookout for.

In this video, Paula Anastasia, RN, MN, AOCN^®, of Cedars-Sinai Medical Center, Los Angeles, describes the common problem of weakness that patients can experience with immune checkpoint inhibitor therapy. She discusses what patients should be on the lookout for.